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The serologic test commonly used at present to detect antibodies to Toxo- 
plasma  is  the methylene blue  dye test  (1).  This method depends  upon  the 
ability of specific antiserum to modify live toxoplasms so that they no longer 
stain with a  methylene blue  solution.  Two  important  difficulties associated 
with this test are that it employs a  live antigen obtained from infected mice 
just before use in the test, and that it requires the presence of a complement- 
like  substance,  "accessory factor,"  which  is  obtained  from  human  serum. 
In  addition,  the  experience  of several  laboratories  (2-5)  has been  that  the 
test is capricious and cannot always be depended upon to yield valid results 
as a  routine, diagnostic method. For this reason,  the potential usefulness of 
a  test which would yield results parallel to those of the dye test, and which 
would avoid the difficulties associated with the latter method would be great. 
The fluorescence inhibition  technique, described in this paper,  seems to offer 
possibilities as a  routine  screening procedure  to  be followed up  by the  dye 
test on detected positives only. From the standpoint of the clinical diagnos- 
tic laboratory,  such an approach  would greatly simplify the  testing of sera 
for  evidence  of  toxoplasmosis.  It  was  from  this  standpoint  that  the 
work  described  here  was  performed. 
Coons and Kaplan (6)  demonstrated that it is possible to block the stain- 
ing  of  antigen  with  homologous  labelled  antibody  by  first  exposing  the 
antigen  to  the  original  non-labelled  antibody.  This  test  for  specificity 
of staining has been widely used in fluorescent antibody studies. When  the 
test was applied to the staining of Toxoplasma gondii with labelled antibody 
(7),  inhibition of fluorescence was very marked, and the possibility was then 
considered that antibody might be detectable in unknown sera by observing 
the  degree of inhibition which such sera demonstrated. The purpose  of this 
paper is to describe the serologic  test for toxoplasmosis which was developed 
on  the  basis  of  this  inhibition  phenomenon,  and  to  present  evidence 
concerning  the  specificity and  reliability of the  method. 
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Materials  and Methods 
Labelled Antibody.--Two labelled sera were used in this work: T-l, a  human serum show- 
ing a  1:4000 titer for toxoplasmosis in the methylene blue dye test, and "1"-3, a  pool of sera 
taken from experimentally infected rabbits? The globulin fraction of this pool had a dye test 
titer of 1 : 16,000. 
The globulin portions of these sera were conjugated with fluorescein by the method of 
Coons and Kaplan (6). When not in use, conjugates were kept frozen at --20°C. 
Antigen.--Smears of T. gondii were prepared from peritoneal exudate of 3- or 4-day in- 
fected mice. The exudate was washed with 0.1  or 1.0 per cent formol-saline, using methods 
described previously (7).  Depending upon the number of smears prepared and the number 
of tests run, smears made from the same batch of exudate were used for up to 1 month. When 
not in use, smears were kept at -20°C. 
Test Sera.--These were primarily human sera submitted for diagnosis to the Toxoplasma 
Diagnostic Laboratory of the Communicable Disease Center over a  period of about 1 year. 
The sera were kept frozen at  --20°C. until used. In most cases, dye tests were also run on 
these specimens.  2 In addition, a group of sera from laboratory and other animals was tested. 
Sera varied in character from fresh, sterile, non-hemolyzed samples to year old, badly con- 
taminated,  and badly hemolyzed specimens,,  but no controlled studies were carried out on 
the influence of these factors upon the test.  Sera that contained much suspended material 
were centrifuged at high speed before being tested. Except for a few preliminary experiments 
in titration, all tests were done with undiluted sera. 
Performance of Inhibition Tests.--In some earlier experiments, variations of the following 
basic technique were used; however, only the method adopted finally is given here. Smears 
were removed from the freezer and allowed to dry thoroughly. Test serum in the amount of 
0.02 ml. was mixed in a  tube with 0.02 ml. of labelled antibody, usually diluted 1 +  2 or 1 
+  4, and the entire mixture was transferred to a smear by means of a bulb-operated pipette. 
The dilution of labelled antibody varied with different batches of smears and was determined 
for each batch by a  titration procedure described in the next section. At first the diluent 
used was 0.85 per cent saline, but later 2.5 per cent bovine serum albumin in 0.85 per cent 
saline was substituted when it was found that results tended to be more clean cut with the 
latter solution. Smears were put into a wet chamber at 37°C. for 1 hour, removed, and im- 
mersed  in saline and tap water for  10 and 5  minutes respectively. They were then dried, 
mounted with buffered glycerol  and  examined with the fluorescence microscope described 
previously (7). 
The degree of fluorescence was recorded by plus marks according to the following guide:-- 
-4---no definite fluorescence, organisms only vaguely visible, indicating strong inhibition; 
1  +---definite fluorescence, color non-descript, not definitely green; 
2+--definite fluorescence, color definitely yellow-green but of low intensity; 
3+--bright yellow-green color, sharp, and clear; 
4+--brilliant yellow-green color, very sharp, indicating no inhibition. 
In order to help the observer determine the amount of fluorescence with some degree of 
objectivity, reflector type neutral density filters were placed in the path of the input light. 
With the fluorescence system used in this work, it was found that a 0.6 density filter greatly 
reduced the yellow-green color of a  2+ fluorescence, but allowed the color of 3+ brightness 
to come through rather clearly. 
1 This serum was made available through the kindness of Dr. Leon Jacobs of the National 
Institutes of Health, Laboratory of Tropical Diseases. 
2 Dye tests were performed by Mr. A. J. Sulzer and Miss Ruth Gogel to whom the author 
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All sera were tested twice as unknowns, and in the earlier experiments they were read 
independently by two individuals. Negative and positive control sera were set up in every 
run, fluorescent results usually being 3-4+ and 1-2+, respectively. 
EXPEPS~NTAL 
One-Step  Inhibition  Test.--Inhibition  tests used  in  the  past  to  prove the 
specificity  of  fluorescent  staining  with  labelled  antibody  have  been  of  the 
sequence  type;  i.e.,  antigen  has  been  exposed first  to  unlabelled  antibody, 
rinsed,  exposed  to  labelled  antibody,  rinsed  again,  and  examined  (6).  The 
first tests performed in the present work with toxoplasms were of this type, 
smears being  covered with  unlabelled  antiserum  for  1  or  2  hours  and  then 
TABLE  I 
Fluorescent Staining  Obtained with  the Sequence and  Combined Method for  Demonstrating 
Inhibition 
Type of smear 
Original exudate 
Exudate  washed  with 
saline 
Exudate  washed  with 
0.1 per cent formol- 
saline 
Sequence method 
Positive serum  Negative serum 
followed by  followed by 
labelled anti-  labelled anti- 
serum (T-l)  serum (T-l) 
2+ 
2+ 
3+ 
Combined method 
Labelled antiserum 
(T-l) plus positive 
fleruln 
1-2+ 
1-2-t- 
2+ 
-+--1+ 
:e-i+ 
1+ 
Labelled antiserum 
(T-l) plus negative 
sel*unl 
34+ 
3+ 
4+ 
with labelled antiserum for 1 hour.  Generally, but not always, inhibition was 
demonstrated  by  this  method.  Reasons  for  partial  or  complete  failures  of 
the test were obscure, but positive results were frequent and clear enough so 
that  in  a  preliminary group of 49  sera  tested as unknowns,  agreement with 
the dye test occurred in about 85 per cent of the cases. At this point a  new 
batch of smears was prepared and  24 more sera were  tested.  In this group, 
agreement  between  dye  and  inhibition  test  results  dropped  to  69  per  cent 
with some serious discrepancies occurring between the results of the two tests. 
Another batch of exudate was obtained and smears were prepared from the 
original exudate, from exudate washed with saline, and from exudate washed 
with 0.1 per cent formol-saline. An inhibition test performed on these smears, 
using the sequence method of exposure, showed very little difference between 
the  effects of known positive and negative  sera.  However, when  the  inhibi- 
tion test was performed by a  one-step procedure in which the uniabelled and 
labelled  sera were combined and  applied  to  the  smears together  (8),  it was 
obvious that the one-step, or combined method demonstrated inhibition much 
more dearly  than  the  sequence  method  (Table  I). Six  new  sets  of  smears, 560  STAINING  TOXOPLASMA  GONDII.  II 
prepared from different batches of exudate on different days and stained  by 
the  combined method,  showed  clear  inhibition  in  all  cases,  indicating  that 
the  method  was  reasonably  dependable.  Since,  in  addition  to  being  more 
dependable,  the  combined method was  also  simpler and  quicker to perform 
than the older test, it was decided that all subsequent testing of sera would 
be  by  this  method. 
Exploratory experiments with  the  combined method showed  that  the  in- 
hibition effect was  a  quantitative matter;  i.e.,  by varying the  relative con- 
centrations  of labelled  and  unlabelled  antisera  one could  obtain  greater  or 
lesser inhibition.  It was  therefore necessary to titrate  the labelled antiserum 
so that the greatest contrast would be developed when the serum was mixed 
with known positive and negative sera. A  typical protocol is shown in Table 
II. In this case, two sera positive in the dye test at different titers, and one 
TABLE  II 
Fluorescent  Staining  Obtained in  Titrating  Labelled Antiserum  in  Order  to  Demonstrate 
Optimum Degree of Inhibition 
Sera added to labelled antiserum (dye 
test titers shown in parenthesis) 
369  (1:64) 
475  (1:16) 
Olden (negative undiluted) 
Undiluted 
4+ 
2+ 
4+ 
Original Dilution of labelled antiserum 
(T-t) 
I-[-1  1+2 
2-3+  1-2+ 
1+  d=-l+ 
3-4+  3+ 
t+3 
1+ 
-4- 
2-3+ 
serum negative undiluted in  the dye test,  were set up in  combination with 
varying  dilutions  of  the  labelled  antiserum.  It  can  be  seen  that  when 
the labelled antiserum was undiluted, little or no inhibition was demonstrated 
by the positive sera, but when the labelled antiserum was diluted out, inhibi- 
tion became clearly visible. A  practical limit to this dilution was  set by the 
intensity of fluorescence in  the presence of negative serum, so that in  the  1 
+  3 dilution, for example, the presumably non-inhibited fluorescent staining 
was too low for adequate observation and comparison with inhibited reaction. 
From  this  titration, a  1 -b  2 dilution of labelled antiserum was  taken as a 
proper concentration for testing.  It should be noticed that No. 475  was  the 
weaker of the positive sera according to the dye test, but was the stronger in- 
hibitor in  the  fluorescence test.  Subsequent  tests confirmed the finding that 
the dye test titer of a serum was  not  always directly correlated with  the de- 
gree of  inhibition  shown  by the  same  serum.  Whenever  new  smears  were 
prepared, a  titration was  run  using previously determined positive and nega- 
tive sera as controls. Although smears from any one batch of exudate remained 
constant in activity at least over the length of time they were  usually used 
for  testing,  different  batches of exudate frequently required slightly different 
dilutions of labelled  antiserum in  order  to  demonstrate inhibition. MORRIS  GOLDMAN  561 
In smears showing no inhibition at all and in smears showing strong  inhibi- 
tion,  essentially all the  toxoplasms were  brightly fluorescent  or  non-fluores- 
cent,  respectively.  However,  in  partially  inhibited  smears,  one  could  fre- 
quently  find on  the  same  smear  organisms  that  varied in  brightness  within 
1  -k  mark.  Generally the distribution of fluorescent material in an organism 
was  rather  uniform  except for  somewhat  brighter  staining  peripherally. 
TABLE III 
Rdationship of Dye and Fluorescence Inhibition Tests in Two Groups of Randomly Sdected Sera 
Test used 
Fluorescence 
inhibition 
test results 
No. of sera at indicated  dye test tlter 
I  f  1:256 and 
<16  1:16  1:64  1  higher  No. of sera 
tested 
GROUP A 
Dye test 
Fluorescence inhibition 
test 1 
Fluorescence inhibition 
test 2 
Negative 
Doubtful 
Positive 
Negative 
Doubtful 
Positive 
37 
5 
2 
44  21 
28  ~ 
4  4 
12  11 
2O 
1 
3 
16 
6 
3 
11 
100 
36 
12 
52 
52 
17 
31 
GROUP B 
Dye test 
Fluorescence inhibition 
test 1 
Fluorescence inhibition 
test 2 
Negative 
Doubtful 
Positive 
Negative 
Doubtful 
Positive 
18  (36)*  12  (24)  12  (24) 
13  (26)  5  (10)  [  5  (10) 
2  (4)  0  3  (6) 
3  (6)  7  (14)  4  (8) 
11  (22)  4  (8)  3  (6) 
3  (6)  0  4  (8) 
4  (8)  8  (16)  .  5  (10) 
8  (16)  -T-- 
1  (2) 
7  (14) 
0 
0 
8  (16) 
50 
23 
6 
21 
18 
7 
25 
* Figure in parenthesis is the percentage based on 50 sera tested. 
Comparison  of Inhibition,  Dye,  and Complement-Fixation  Tests.--One  hun- 
dred sera chosen at random,  (group A), were tested twice in  groups of 20 to 
30  at a  time. Exposure  time in this group was 30 minutes at 37°C.  The dis- 
tribution  of the  two  sets  of fluorescence  inhibition results  as related  to  dye 
test titers is shown in Table III? It was obvious that correlation between the 
two types of tests and between duplicate inhibition tests was poor. A  critical 
In accordance  with recommended  procedures  for performing the dye test for diagnostic 
purposes, the lowest dilution used in the test was 1:16. Sera negative at this level have been 
designated <1:16 in the tables and text. This group, then, includes sera which might have 
shown positive titers in the lower dilutions or might have been negative undiluted. 562  STAINING  TOXOPLAS~-A  GONDII.  II 
check was  then made of technical  aspects of the  inhibition  test and several 
changes were instituted.  Care was taken to make sure that  smears removed 
from the freezer for use  were very thoroughly dried  before exposure to  the 
test mixture;  smears were made smaller  than  before  to  assure  adequate  ex- 
posure of all organisms; and exposure time at 37°C.  was increased  to  1 hour 
so  that  the  amount  of time elapsing  between  exposure of the  first and  last 
smears of a  set would  be a  smaller percentage of the incubation period. 
Using  the modified procedure,  a  new group of 50 random sera,  (group B), 
was  tested  in  duplicate.  In  this  series  agreement  between  duplicate  inhibi- 
tion tests was closer than before in all categories (Table III). The total num- 
ber of positives in the first test was 21  (42 per cent), and in  the second test 
25  (50 per cent),  whereas  comparable figures for the  results  of the  first  100 
sera were 52  and 31  per cent.  Thus,  it  appeared that  the  changed methods 
of setting  up the  tests had considerably improved reproducibility of results. 
However,  correlation  between  dye and  inhibition  test  results  was  still  poor 
in  the  group  of sera  with  dye  test  titers  less  than  1:256. 
Inasmuch as the 150 sera in groups A and B  were chosen at random,  there 
did  not always exist sufficient clinical  information to evaluate  the  results of 
the serological tests.  In order to gain more definite information as to the re- 
lationship  of  the  inhibition  test  to  actual  infection  with  toxoplasmosis,  two 
new groups of sera were tested (Table IV). In group C, 25 sera were selected 
in  which  the  clinical  history was  suggestive of congenital  toxoplasmosis and 
in  which  the  dye  test  results  supported  such  a  diagnosis.  Duplicate  inhibi- 
tion  tests in  this group gave the  same results  in all but  2  cases which  were 
both positive in  one  test and  doubtful  in  the  other.  In addition,  agreement 
with the dye test was much better than in groups A and B, the only difference 
occurring with serum 217 which had a  titer of <1:16 in the dye test but was 
positive in  the  inhibition  test.  This discrepancy,  and  others  which  occurred 
in  the  next group tested,  will be taken  up in  the  Discussion. 
In  group D,  25  sera were  selected from patients  with  histories  suggestive 
of congenital toxoplasmosis, basing this mostly on the presence of eye lesions, 
but  where  the  dye  test  results  did  not  always  confirm  such  a  diagnosis. 
Duplicate  inhibition  tests gave the  same results  in  20  cases;  in  the  other  5 
cases, results were doubtful in one test and either positive or negative in the 
duplicate test. Out of 5 cases positive at 1:16 in the dye test, one was  doubt- 
ful and negative, one was doubtful  and positive, two were positive, and  one 
was negative by the  inhibition  test.  Out  of 4  cases positive at  1:64  by the 
dye  test,  one was  doubtful  and  three  were  positive by inhibition  test.  The 
single  case positive at  1:256  by the dye  test was also positive by inhibiton 
test. Out of 16 cases <  1:16 by dye test, 8 were negative by duplicate inhibi- 
tion tests,  2 were doubtful and negative, one was doubtful and positive, two 
were doubtful and 3  were positive. If one interprets a  1:16  dye test titer as MORRIS  GOLDMAN  563 
a  borderline positive, and  if one considers a  positive or  negative  inhibition 
test coupled with a  doubtful reaction in the duplicate test as being a border- 
line reaction, then the results obtained in group C and D  can be summarized 
as follows: Out of 50 cases with reasonably satisfactory clinical histories,  27 
were definitely positive by dye test,  and 30  were definitely positive by the 
inhibition test;  duplicate  inhibition tests  showed no  serious differences and, 
in general,  there was very good agreement between the  dye and the inhibi- 
tion  tests. 
The results obtained in  groups  C  and D  indicated  that  with  these  types 
of sera  the inhibition test  was reproducible to a  high  degree and its results 
paralleled those of the dye test. In order to compare the results of the inhibi- 
tion test with those of the complement-fixation (C-F)  test for toxoplasmosis, 
an additional group of 100 random sera (group E) was tested. For 30 of these, 
both dye and C-F test results  4 were available; the other 70 had been tested 
previously only by the  C-F test. The results of the dye test,  duplicate inhi- 
bition  tests,  and  C-F  tests  on  the  first  30  sera  are  given  in  Table  V. 
The parallelism of the inhibition and dye tests in this group is evident.  Out 
of 15 sera  <1:16 by dye test, 12 and 13 were negative or doubtful by dupli- 
cate  inhibition  tests,  3  and  2  sera,  respectively,  were  positive  by  the 
inhibition method. Out of 6  sera positive by the dye test at  the low titer of 
1:16,  4  and  3  were  positive  by  duplicate  inhibition  tests,  2  and  3, 
respectively, were negative or doubtful.  Out of 9 sera positive by dye test at 
a titer 1:54 or higher, 8 and 7 were positive by inhibition tests, and the other 
1 and 2 sera were negative or doubtful. On the other hand,  the lack of cor- 
relation between the inhibition test and the  C-F test was shown by the fact 
that  the  latter  method  detected only one positive  in  the group,  compared 
to 12 or 15 positives detected by the inhibition method. A comparison of C-F 
and inhibition test results for the  other 70  sera is shown in Table  VI. Again, 
it is obvious that the inhibition test detected many more positives (24 to  1) 
than  the  C-F test. In the over-all group of 100 sera, there were 39 positives 
reported by one inhibition test, and 36 by the other; 5 cases which were nega- 
tive in one inhibition test were positive in the duplicate test and there were 
27 sera which were positive or negative in one test and doubtful in  the dup- 
licate  run. 
Inhibition  Tests with Known Heterologous Antisera.--Up  to  this point,  the 
specificity of the inhibition test for Toxoplasma  antibodies was based on cor- 
relation with  the  dye test  and  clinical  histories.  Since questions  have  been 
raised  concerning the  specificity of the  dye test  (5),  another  approach  was 
used to judge the kind of antibodies revealed by the inhibition test. Sera were 
4 Complement-fixation tests were performed by the Serology Laboratory  of the Parasi- 
tology and Mycology Section, Communicable Disease Center,  Atlanta, using antigen pre- 
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TABLE  IV 
Relationship  of Dye Test, Fluorescence Inhibition Test, and Clinical Histories  in 50 Sdected  Sera 
Reciprocal  Fluorescence  Fluorescence 
Serum  of dye test  inhibition  inhibition  History 
No.  result  test 1  test 2 
Croup C 
217  < 16  Positive  Positive 
218 
6O5 
606 
696 
697 
705 
739 
740 
748 
749 
771 
772 
776 
796 
797 
801 
824 
826 
836 
256 
64 
256 
64 
256 
1024 
65,000 
16,000 
64 
256 
64 
256 
64 
256 
256 
256 
1024 
1024 
1024 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Doubtful 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Doubtful 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Doubtful 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
13  yrs.  old;  bilateral chorioretirdtis, fast de- 
terioration  of  vision  past  2  years,  active 
lesions. 
Mother of No. 217; no symptoms. 
2 mos.  old; chorioretinitis, convulsions, cere- 
bral calcifications. 
Mother of No. 605; no symptoms. 
Repeat specimen on No. 605,  1 mo. later. 
Repeat specimen on No. 606,  1 too. later. 
Mother of baby which died with brain calci- 
fications. 
4  mos.  old;  chorioretinitis,  hydrocephalus, 
cerebral  calcifications,  enlarged  liver  and 
spleen. 
Mother of No.  739; no symptoms. 
12 yrs. old; chorioret/nitis, hydrochephalus of 
long standing. 
Mother of No. 748; no symptoms. 
11 yrs. old; old chorioretinitis. 
Mother of No.  771; no symptoms. 
Patient's infant had fever and hydrocephalus, 
no serology available on infant. 
Repeat of No. 217, 6 mos. later. 
Repeat of No. 218, 6 mos. later. 
Mother of premature infant which died at  1 
day with small brain lesions. 
19 yrs. old; active chorioretinitis. 
Mother  of  child  with  chorioretinitis;  no 
serology on child. 
Mother of baby with high titer for toxoplas- 
mosis. MORRIS  GOLDMAN 
TABLE IV---Continued 
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I 
Reciprocal  Fluorescence  Fluorescence 1 
Serum  of dye test  inhibition  inhibition  History 
No.  result  test 1  test  2 
Group C (Continued) 
866  256  Positive  Positive 
869 
870 
1084 
1129 
256 
256 
1024 
64 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
Adult  with  brain  lesions  containing  toxo- 
plasma pseudocysts. 
19 mos. old. 
Mother of No. 869; no symptoms. 
Repeat of No. 705, 4 mos. later. 
7 yrs. old; chorioretinitis, mentally retarded. 
Group D 
784 
785 
1047 
1048 
1051 
1052 
1063 
1068 
1069 
1071 
1072 
1079 
1080 
1089 
1090 
1091 
1092 
<16 
16 
64 
<16 
<16 
<16 
16 
<16 
<16 
<16 
<16 
<16 
<16 
<16 
16 
<16 
<16 
Positive 
Positive 
Doubtful 
Negative 
Positive 
Positive 
Negative 
Negative 
Doubtful 
Negative 
Negative 
Doubtful 
Doubtful 
Doubtful 
Positive 
Doubtful 
Negative 
Positive 
Positive 
Doubtful 
Negative 
Positive 
Positive 
Doubtful 
Negative 
Negative 
Negative 
Negative 
Doubtful 
Doubtful 
Positive 
Doubtful 
Negative 
Negative 
16  mos.  old;  chorioretinitis,  rash,  psycho- 
motor retardations, pneumonitis. 
Mother of No. 784, no symptoms. 
10  months  old;  bilateral  chorioretinitis, 
hydrocephalus. 
Mother of No. 1047, no symptoms. 
10 yrs. old; chorioretinitis, convulsions. 
Mother of No. 1051, no symptoms. 
11  yrs.  old;  chorioretinitis,  convulsions, 
cerebral calcifications, microcephaly. 
8  mos.  old;  chorioretinitis,  convulsions, 
psychomotor retardation. 
Mother of No. 1068, no symptoms. 
Newborn; chorioretinitis, microcephaly. 
Mother of No. 1071, no symptoms. 
13  yrs,  old; chorioretinitis,  psychomotor  re- 
tardation, microcephaly. 
Mother of No. 1079, no symptoms. 
4  mos.  old;  chorioretinitis,  psychomotor  re- 
tardation. 
Mother of No. 1089, no symptoms. 
4  yrs.  old;  chorioretinitis,  nystagmus,  re- 
tarded. 
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TABLE  IV--Cond4M~'A 
Reciprocal  Fluorescence  Fluorescence ] 
Serum  of dye test  inhibition  inhibition  History 
No.  result  test 1  test 2 
Group D  (Continued) 
1096  <16  Negative  Negative 
1107 
1118 
1119 
1130 
1120 
1126 
1127 
256 
<16 
<16 
16 
64 
16 
64 
Positive 
Negative 
Negative 
Positive 
Positive 
Negative 
Positive 
Positive 
Negative 
Negative 
Positive 
Positive 
Negative 
Positive 
13 yrs. old; chorioretinitis, cerebral calcifica- 
tions, hydrocephalus. 
Adult with chorioretinitis scars in each eye. 
2 mos.  old; chorioretinitis, convulsions. 
Mother of No. 1118, no symptoms. 
7 yrs. old; chorioretinitis, fever. 
Mother of No. 1130, no symptoms. 
16 yrs. old; chorioretinitis, scars since 2 yrs. 
old, acute choroiditis. 
Mother of No. 1126, no symptoms. 
TABLE  V 
Relationship of Dye, Fluorescence Inhibition and Complement-Fixation Tests on 30 Randomly 
Sdected Sera 
Group .E 
Test used 
Dye test 
Fluorescence inhibition 
test 1 
Fluorescence inhibition 
test 2 
Complement-fixation 
test 
Test results 
Negative 
Doubtful 
Positive 
Negative 
Doubtful 
Positive 
Negative 
Doubtful 
Positive 
No. of sera at indicated dye test titer 
<16 
15  (50)* 
7  (23) 
S  (17) 
3  (10) 
8  (27) 
S  (17) 
2  (7) 
14  (47) 
1  (3) 
0 
1:16 
6  (20) 
1  (3) 
1  (3) 
4  (13) 
2  (7) 
1  (3) 
3  (10) 
6  (20) 
0 
0 
1:64 
7  (23) 
1  (3) 
0 
6  (20) 
0 
1  (3) 
6  (20) 
5  (17) 
1  (3) 
1  (3) 
No. of sera 
tested 
30 
9 
6 
15 
10 
8 
12 
26 
3 
1 
* Figure in parenthesis is the percentage based on 30 sera tested. 
obtained from  111  animals before  and  after  immunization or  infection with 
a  variety of antigens. Another 11 postimmunization sera were obtained where 
preimmunization sera  were  not available. Each  of  the  animals had  been  ex- 
posed  to  one  of  the  following  antigens:  Salmonella  sp.,  Pasteurella  pestis, MORRIS  GOLDMAN  567 
Pasteurella  pseudotuberculosis,  Streptococcus  sp.,  Malleomyces  mallei,  Malleo- 
myces pseudomaUei,  Bacterium tularense, 9 serotypes of Leptospira,  Trichinella 
spiralis,  ScMstosoma  mansoni,  Trypanosoma  gambiense,  Entamoeba  kistolytica 
and agents of lymphocytic choriomeningitis, vaccinia, St. Louis encephalitis, 
psittacosis,  rabies,  and  typhus.  Using  standard  serological  procedures  for 
the particular antigen, all postimmunization sera  showed distinct and  often 
high antibody titers to the homologous antigens. Inhibition tests with these 
sera showed no instances of positive reactions in postimmunization sera when 
the  corresponding preimmunization serum was negative.  Eighty two of the 
donor animals in this series  were rabbits.  One of these was doubtful before 
immunization with P.  pestis  and was positive  15  days later when the  tube 
agglutination  titer  for  the  homologous antigen  was  1:640.  Another  rabbit 
was positive by inhibition test both before and after immunization; the dye 
TABLE VI 
Rdationskip  of  Fluorescence Inhibition  and  Complement-Fixation Tests on  70  Randomly 
Selected Sera 
Group E 
Test 
Fluorescence inhibition  test 1 
Fluorescence inhibition  test 2 
Complement-fixation  test 
Negative 
33 
28 
66* 
Results 
Doubtful 
13 
18 
3 
Positive 
24 
24 
l 
* Includes one serum which was anti-complementary. 
test titer for both sera turned out to be 1:1024. Out of 14 humans tested, 1 
was positive by inhibition test both before and after immunization, the others 
were negative. The other donor animals in this series were distributed among 
the following species:mice, rats, hamsters, guinea pigs, goats, chickens, horses, 
cows, pigs, pigeons, turkeys, sheep, and monkeys. No definitely positive inhi- 
bition tests were obtained in any of these. 
DISCUSSION 
The phenomenon of inhibition of specific staining, whether by the sequence 
or combined method, seems to be readily explainable in terms of competition 
by labelled and  non-labelled antibody molecules for available  antigen sites. 
It has been shown that introduction of fluorescein into bovine serum albumin 
did not alter significantly the size,  shape  and homogeneity of the precursor 
molecules (9).  If this is also true for antibody globulin, then in mixtures con- 
taining  both  labelled  and  non-labelled  antibody,  the  degree  of  brightness 
of the antigen-antibody complex would depend upon the relative concentra- 
tions  of  the  two  types  of  antibody.  It  is  not  known  why  the  combined 
method showed clear-cut inhibition with material that gave poor results by 568  STAINING  TOXOPLASMA  GONDII.  II 
the  sequence method.  This phenomenon has  also  been  noted  with  bacteria 
(8), and therefore is not explainable entirely in terms of the species of organ- 
ism  involved. 
The best reproducibility with the inhibition test was obtained in sera from 
cases selected on  the  basis  of clinical histories  (groups  C  and  D).  In  these 
groups there were no reversals of positive and negative results in  duplicate 
tests.  In the groups chosen at random  (B and E),  greater variation was en- 
countered  so  that  there  was  a  3  to  4  per  cent  difference in  the  number 
of positives reported by the duplicate tests. On the basis of available informa- 
tion,  one  can  only speculate  on  the  reasons  for  the  discrepancies  between 
duplicate  tests.  Inhibition  tests  reported  in  this  paper  involved  pipetting 
0.02 ml. quantities of sera. It is possible  that, in cases of sera with borderline 
amounts of antibody, small errors in pipetting  might have had sufficient rela- 
tive effect to change the results of the test.  This viewpoint is supported  by 
several facts: in most cases of reversals from positive  to negative, inhibition 
was not very marked even when the result was positive; in all of the groups 
tested, the number of sera which changed from  doubtful to negative or posi- 
tive in  the  duplicate  test  was  always  considerably greater  than  those  that 
changed from definitely positive  to  definitely negative;  fewest reversals oc- 
curred in group  C  in which  clinical histories  and  dye test results indicated 
the  definite presence of antibody,  whereas  the greatest number  of reversals 
occurred in  a  randomly selected group in which  sera  might  be  expected to 
contain varying amounts of antibody. In addition to the factor of pipetting, 
the subjective estimation of degree of fluorescence is undoubtedly a  possible 
source of error particularly, again,  in borderline cases. Readings of the same 
smears by two individuals showed slight variations which did not affect the 
distinctly positive and  distinctly negative  results,  but  which  did  affect the 
doubtful  type  of  reaction.  The  use  of  a  simple  and  objective  method 
for determining brightness of fluorescence would be a  great help but, as yet, 
only the method of using neutral density filters as described above has been 
tried.  From a  practical standpoint,  if variation can be limited  to borderline 
cases only, the results of the test could still be considered significant. If the 
test has validity in  relation to infection with  Toxoplasma, a  change in suc- 
cessive sera,  drawn  at  different times,  from a  borderline reaction  to  either 
definitely positive or definitely negative could still be interpreted. 
In  interpreting  the  significance of inhibition  test  results,  it  is  proper  to 
consider first the results of testing  122  sera containing antibody to antigens 
other  than  Toxoplasma. In  this  group of postimmunization sera  there  were 
no  cases  in  which  individuals  changed  from  negative  to  positive following 
immunization or infection with non-Toxoplasma antigens,  and only one case 
of  a  doubtful  reaction  becoming  positive  after  immunization.  Since  con- 
ventional serological procedures had  demonstrated  the presence of consider- MORRIS GOLDMAN  569 
able  homologous antibody in  the postimmunization sera  in  this group,  it  is 
reasonable to conclude that  the inhibition test described here is not affected 
by  the  presence  of  many  non-Toxoplasma  antibodies.  It  would  have  been 
desirable  to  include  in  this  series  more  animals  immunized  with  protozoan 
antigens  but  these were not available at  the  time. The question of possible 
cross-reactions with such forms as Sarcocystis, Trichomonas, and Leishmania 
remains  unanswered. 
Since interpretation  of the  inhibition results  has  been  based mostly on a 
comparison with  the  results  of dye and  complement-fixation tests  and  with 
clinical histories, a brief interpretation of the results of these latter tests may 
be  helpful  at  this  point. 
Available evidence indicates that dye test antibodies appear relatively soon 
after infection, within a few weeks or less, whereas complement-fixing antibodies 
do not appear until  later.  In addition,  dye test antibodies persist in  dimin- 
ishing  titers  for many years beyond  the  period  of acute  infection,  whereas 
complement-fixing  antibodies  diminish  sharply  or  disappear  within  2  to  4 
years. It follows from this that infants born with active infections may show 
distinct  dye  test  titers  but  still  be  negative  by complement-fixation. Ordi- 
narily  their  mothers  will  have  high  titers  in  both  tests  (10).  Serological 
evidence of infection with toxoplasmosis during a  specific time period can be 
established by showing a  rise in dye test  titer, generally to a  level of 1:256 
or more; or if the dye test remains constant at high level, by showing a signif- 
icant rise in complement-fixation titer.  Consistently moderate dye test titers 
in  the  consistent absence  of complement-fixing antibodies may be  taken  to 
indicate  an  old  infection  with  toxoplasmosis;  this  condition  is  commonly 
found in adults.  In infancy and childhood chorioretinopathy is an important 
sign for the  selection of patients  in whom  toxoplasmosis is suspected,  since, 
in  the  absence of chorioretinal lesions,  serologic confirmation of infection is 
very  low  (11). 
Table IV, which presents inhibition and dye test results on each of 50 sera 
tested,  shows  the  close parallelism  between results  of the  two  tests.  In  the 
discrepancies which occurred it was impossible to say for sure which result was 
more accurate because further study of the cases concerned was not possible. 
However, some presumptive  analyses  are  possible.  In  the  case  of No.  217, 
the positive result of the inhibition test is more in accord with presently ac- 
cepted interpretations of toxoplasma serology than the  < 1:16 or "negative" 
result  of  the  dye  test.  When  this  13  year  old  child  was  retested  6 
months later,  (No.  796),  both the dye and inhibition tests were positive. If 
the  positive  titer  was  related  to  the  active  chorioretinal  lesions  exhibited 
then  the  first serum  (No.  217)  should have been positive by dye test  also, 
since  there  was  evidence of visual  deterioration for 2  years before the  first 
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The  results  of  the  dye  test  and  inhibition  test  on  paired  sera  784- 
785,  1051-1052,  1089-1090,  and  1126-1127  differ to some degree,  but  either 
set of results  is  compatible with  accepted  theory. 
Serum 1047 was positive at 1 : 64 in the dye test, but was doubtful in the in- 
hibition  test.  Since  this was from a  10 month old infant whose mother, No. 
1048,  was negative by both  tests,  the positive dye test on the infant is un- 
expected.  Clinically,  there  was  reason  to  suspect  congenital  toxoplasmosis 
but serologically such  a  diagnosis could not be made unless  the mother also 
showed  a  high  dye  test  titer.  The possibility exists  that  this  was  a  case  of 
acquired  toxoplasmosis in  the  infant  but  there  was  no  clinical  evidence  to 
support such a view. The simpler and more likely explanation is that the clin- 
ical symptoms were due to reasons other than toxoplasmosis, and that the dye 
test was in error in  this  case. 
A greater number of discrepancies between the two tests occurred in groups 
B  and  E,  in which  sera were chosen at  random.  From Tables III and  V  it 
can  be  seen  that  most  of  the  discrepancies  occurred  in  sera  with  dye 
test titers of 1:15 and 1:64.  From 51  to 72 per cent of the 1:15 dye test sera, 
and from 58  to 84 per cent of the  1:64 dye test sera were found positive or 
doubtful by the inhibition  test,  depending upon which of the duplicate inhi- 
bition results is used.  Conversely, from 35 to 45 per cent of sera with dye test 
titers  of  <1:15  were  positive  by  the  inhibition  test. 
Causes for discrepancies between the two tests may be divided into inher- 
ent  and  technical  reasons.  Some  obvious  inherent  reasons  may be:  (a)  the 
tests  measure  different  antigen-antibody  systems  which  may  or  may  not 
coincide in any one serum; (b)  the antigen-antibody systems may be the same 
but the dye test is more sensitive and therefore picks up some positives that 
are missed by the inhibition test;  (c)  an anti-accessory factor substance may 
be present in some sera which may cause the dye test to appear negative even 
though antibody is present and detectable by the inhibition test; and (d)  the 
remarkable sensitivity of the  dye test may result  in  the  detection  at  a  low 
titer of non-specific antibodies which  are non-reactive in  the  inhibition  test. 
These possible reasons  cannot be either confirmed or denied  on the basis of 
available evidence. 
Technical bases  for discrepancies  may be  the  variations  which  can  occur 
in replicate  tests of sera by both  the dye and inhibition  test.  Since fourfold 
differences in the dye test titers of aliquots of the same serum are not unex- 
pected (4),  the number and identity of sera showing any given titer is likely 
to be different when a  large enough group of randomly selected sera is tested 
more than once.  In a  group of 50 sera, aliquots of which were dye-tested as 
unknowns  by four different,  established  laboratories,  there  were  25  cases of 
Jourfold differences in titer, and seven cases of 16-fold differences among some MORRIS  GOLDMAN  571 
of the laboratories.  5 Most of the  1:16 and  1:64 dye test titers referred to in 
this paper are the results of single, screening tests. It might well be expected 
that in retesting such sera there would be shifts in the titers obtained in at 
least some of the cases. Under those circumstances the interpretation of some 
discrepancies between the dye and inhibition test results is well nigh impos- 
sible.  Some of the technical sources of variation in the inhibition  test  have 
already been discussed in comparing the results of duplicate tests. 
If  the  inhibition  test  is  to  serve as  an  adequate  screening procedure for 
clinical diagnosis,  to be followed up with the dye test,  it should pick up as 
positive or doubtful those cases whose dye test titers are indicative of current 
or  recent  Toxoplasma infection.  At  present,  authoritative  interpretation  of 
dye  test  results  suggest  that,  in  general,  titers  lower  than  1:256  on  single 
serum  samples  are  difficult to relate  to  clinical disease,  although  in  certain 
types  of  eye  lesion  cases  the  titer  may  be  lowered  to  1:64  (11,  12).  In 
the work reported here, all sera with dye test titers of 1:256 or higher were 
positive or doubtful by the inhibition test;  the same result was  obtained in 
all sera from the clinically selected groups  C  and D  which showed titers of 
1:64. In the randomly selected groups B  and E  some 1:64 sera were negative 
by the  inhibition test.  Not enough sera have been tested  to know whether 
this difference between the results obtained with group C  and D  and groups 
B  and E  is significant or not. 
From the practical standpoint,  the inhibition test has several advantages 
over the dye test as a  routine procedure. Foremost is the fact that it uses a 
killed, standardized antigen which can be prepared in batches that are useful 
for about a  month at a  time. This contrasts with the dye test requirement 
of fresh live antigen obtained from infected mice immediately before use in 
the test. The dye test requires accessory factor, for which the only source at 
present is human serum.  Since, in our experience, only about one in twenty 
young adults is a  suitable donor, a  reliable supply of this substance is a  con- 
stant  problem.  The  inhibition  test  does  not  require  accessory  factor. 
Reference has already been made to the variability of the dye test. Since the 
entire test must be set up and run before one can tell whether the controls 
are proper for the day, this variability results in the loss of much time. The 
relative simplicity of the mechanics of the inhibition test, and the use of pre- 
viously titrated antigen and labelled antibody makes the routine performance 
of  the  inhibition  test  easier  and  more reliable. 
The general procedures of the inhibition test are such that the test may be 
useful in  the diagnosis of other conditions besides toxoplasmosis. The cyto- 
5 Unpublished  data  from the Toxoplasma Diagnostic Laboratory  of the Communicable 
Disease Center~  Atlanta, which, under the direction of Dr. M. M. Brooke, is acting as dis- 
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chemical nature of the test means that only a  relatively few cells or antigen 
particles  are  needed  in  order  to  test  a  serum,  whereas  large  amounts 
are  generally  needed  if  one  uses  extraction  methods  to  prepare  soluble 
antigens.  For example, in  this laboratory,  1 ml.  of mouse exudate serves  to 
screen only about 15 sera by the complement-fixation test, but by the inhibi- 
tion test about  200 sera can be screened with  the same volume. This is not 
too significant in Toxoplasma testing because organisms are readily obtained 
in  large  numbers  from infected mice,  but  it  may be  significant in  working 
with  agents like viruses or amebae. 
There are  important problems  and  difficulties associated  with performing 
the  inhibition  test  which  need  emphasis.  A  dark  room,  with  the  attendant 
problems of heating and cooling, is a  necessity if the test is to be done with 
any sort of regularity.  Fluorescence equipment is readily available commer- 
cially nowadays, but most technicians are not familiar with such equipment 
or with fluorescence methods and  would need special training  for the work. 
The subjective nature  of reading  test  smears  at  present  may influence the 
reproducibility of results  from  one  laboratory  to  another.  The preparation 
of  labelled  serum  and  Toxoplasma smears  would  probably  be  beyond  the 
capabilities  of most  smaller  laboratories.  However,  such  material  could  be 
prepared centrally and  be readily distributed  to peripheral laboratories. 
SUMMARY 
A  new  serologic  test  for antibodies  to  Toxoplasma is  described,  which  is 
based upon inhibition of specific staining  with fluorescent antibody.  In per- 
forming the test, a  mixture of the test serum and known fluorescein-labelled 
antiserum is added  to a  dried smear of toxoplasms for I  hour at 37°C. The 
smear is then rinsed and examined with a fluorescence microscope. Reduction 
in  the brightness  of fluorescence, as compared to  that  of a  negative control 
slide,  indicates  the  presence  of  antibody in  the  test  serum. 
A  comparison of the results of this test with  those of the methylene blue 
dye test showed a  strong parallelism between the two sets of results. On the 
other  hand,  the  complement-fixation  test  for  toxoplasmosis  did  not  yield 
nearly as many positives as  the inhibition  test. 
The specificity of the new  test was studied by comparing it with dye test 
results  and  clinical  histories  in  human patients,  and  by testing  a  group  of 
animals immunized with a  variety of non-Toxoplasma antigens.  No evidence 
of cross-reactions was  obtained  in  the  latter  series. 
Some advantages  and  disadvantages  of  the  inhibition  test  are  discussed. 
The author wishes to acknowledge his indebtedness to Mr.  Russell K.  Carver who as- 
sisted in many of the serum testing experiments involved in this work. 
Many individuals all  over the country cooperated in  supplying from their own experi- 
mental stocks the heterologous antisera used in this work and information concerning homol- 
ogous titers. The author is greatly indebted to them for their kindness. MORRIS GOLDMAN  573 
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